GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Panacos Pharmaceuticals, Inc. (PANC) [hlAlert]

Rating:
Hold PANC

Panacos Pharmaceuticals, Inc. (PANC) rated Hold

Posted on: Tuesday,  Dec 11, 2007  9:25 AM ET by Stifel Nicolaus

Panacos Pharma (PANC)
rated Hold by Stifel Nicolaus.

Panacos Pharmaceuticals, Inc. (Panacos) is a development-stage biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The Company's lead product candidate, bevirimat, is an oral HIV drug candidate in Phase II clinical testing. Panacos has dosed over 485 patients and subjects with bevirimat and have seen a good safety and tolerability profile with no indication of a relationship between adverse events and drug levels. The Company has exclusive rights from University of North Carolina at Chapel Hill (UNC) to the United States patent claiming the chemical entity bevirimat. Panacos has an exclusive worldwide license with UNC for all indications.

Stifel Nicolaus research focuses on all market caps, but is a leader in small- and mid-cap research. The department is staffed predominately with industry professionals from outside Wall Street. In fact, approximately 50% of its analysts have hands-on work experience in the industry that they research. Stifel Nicolaus believes industry experience, its opportunistic approach, and broad market cap coverage drive excess returns and its award-winning franchise.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/11/2007 9:25 AM Hold
None
1.05
as of 12/24/2008
1 Week up  300.00 %
1 Month down  -33.33 %
3 Months down  -42.85 %
1 YTD down  -71.42 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy